Sean A. McCarthy, CEO at CytomX Therapeutics, Inc. (CTMX), sold 20,223 shares at $2.09 ($42K) on 2024-03-19, disclosed to the SEC on 2024-03-21.
Open-market sale of $42k CTMX by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CTMX | SELL | 2025-11-10 | $924K | — | Filing → |
| CTMX | SELL | 2025-06-17 | $299K | — | Filing → |
| CTMX | SELL | 2025-03-20 | $23K | — | Filing → |